In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $53.15 in the prior trading day, Sanofi ADR (NASDAQ: SNY) closed at $52.27, down -1.66%. In other words, the price has decreased by -$1.66 from its previous closing price. On the day, 2.13 million shares were traded.
Ratios:
Our goal is to gain a better understanding of SNY by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 16.25 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.99. For the most recent quarter (mrq), Quick Ratio is recorded 0.73 and its Current Ratio is at 1.08. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.17.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Exane BNP Paribas on April 15, 2025, initiated with a Outperform rating and assigned the stock a target price of $65.
On March 21, 2025, Goldman started tracking the stock assigning a Neutral rating and target price of $65.
Valuation Measures:
As of this moment, Sanofi’s Price-to-Earnings (P/E) ratio for their current fiscal year is 21.83, and their Forward P/E ratio for the next fiscal year is 10.39. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.65. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.86 while its Price-to-Book (P/B) ratio in mrq is 1.63.
Stock Price History:
Over the past 52 weeks, SNY has reached a high of $60.12, while it has fallen to a 52-week low of $45.80. The 50-Day Moving Average of the stock is -4.43%, while the 200-Day Moving Average is calculated to be -1.56%.
Shares Statistics:
A total of 2.61B shares are outstanding, with a floating share count of 2.43B. Insiders hold about 0.02% of the company’s shares, while institutions hold 10.80% stake in the company.
